Published in Science Translational Medicine · View the paper (DOI)
Researchers successfully repaired a defective gene in blood-forming stem cells from patients with X-linked chronic granulomatous disease, suggesting a potential treatment approach. The study used CRISPR-Cas9 technology to correct a specific mutation in the CYBB gene, restoring normal functioning of white blood cells.
Coverage from 2 institutions